Cubist Systematic Strategies’s Repligen RGEN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $25.8K | Sell |
193
-60,897
| -100% | -$7.4M | ﹤0.01% | 2887 |
|
|
2025
Q2 | $7.6M | Buy |
+61,090
| New | +$7.77M | 0.03% | 766 |
|
|
2024
Q3 | – | Sell |
-6,196
| Closed | -$781K | – | 3414 |
|
|
2024
Q2 | $781K | Buy |
6,196
+5,339
| +623% | +$837K | 0.01% | 1897 |
|
|
2024
Q1 | $158K | Buy |
+857
| New | +$163K | ﹤0.01% | 3161 |
|
|
2023
Q3 | – | Sell |
-51,782
| Closed | -$7.33M | – | 3825 |
|
|
2023
Q2 | $7.33M | Buy |
51,782
+37,749
| +269% | +$6.05M | 0.05% | 614 |
|
|
2023
Q1 | $2.36M | Buy |
14,033
+13,754
| +4,930% | +$2.45M | 0.01% | 1541 |
|
|
2022
Q4 | $47.2K | Sell |
279
-57,397
| -100% | -$10.4M | ﹤0.01% | 3910 |
|
|
2022
Q3 | $10.8M | Buy |
57,676
+30,283
| +111% | +$6.39M | 0.06% | 428 |
|
|
2022
Q2 | $4.45M | Sell |
27,393
-1,398
| -5% | -$221K | 0.03% | 1093 |
|
|
2022
Q1 | $5.42M | Buy |
28,791
+5,078
| +21% | +$965K | 0.05% | 668 |
|
|
2021
Q4 | $6.28M | Sell |
23,713
-4,612
| -16% | -$1.24M | 0.06% | 494 |
|
|
2021
Q3 | $8.19M | Buy |
28,325
+18,289
| +182% | +$4.69M | 0.1% | 257 |
|
|
2021
Q2 | $2M | Sell |
10,036
-9,560
| -49% | -$1.85M | 0.02% | 1084 |
|
|
2021
Q1 | $3.81M | Buy |
19,596
+14,927
| +320% | +$3.06M | 0.05% | 590 |
|
|
2020
Q4 | $895K | Sell |
4,669
-2,184
| -32% | -$397K | 0.01% | 1452 |
|
|
2020
Q3 | $1.01M | Sell |
6,853
-33,362
| -83% | -$4.77M | 0.02% | 1331 |
|
|
2020
Q2 | $4.97M | Buy |
40,215
+40,208
| +574,400% | +$4.73M | 0.09% | 346 |
|
|
2020
Q1 | $1K | Buy |
7
+2
| +40% | +$193 | ﹤0.01% | 2121 |
|
|
2019
Q4 | $0 | Sell |
5
-20,749
| -100% | -$1.74M | ﹤0.01% | 2523 |
|
|
2019
Q3 | $1.59M | Buy |
20,754
+713
| +4% | +$62.4K | 0.03% | 736 |
|
|
2019
Q2 | $1.72M | Buy |
20,041
+13,385
| +201% | +$912K | 0.03% | 750 |
|
|
2019
Q1 | $393K | Sell |
6,656
-62,784
| -90% | -$3.61M | 0.01% | 1334 |
|
|
2018
Q4 | $3.66M | Buy |
69,440
+68,840
| +11,473% | +$4.04M | 0.17% | 102 |
|
|
2018
Q3 | $33K | Buy |
+600
| New | +$30.9K | ﹤0.01% | 1756 |
|
|
2017
Q4 | – | Sell |
-23,288
| Closed | -$892K | – | 2063 |
|
|
2017
Q3 | $892K | Buy |
23,288
+12,388
| +114% | +$519K | 0.05% | 492 |
|
|
2017
Q2 | $452K | Buy |
+10,900
| New | +$414K | 0.03% | 802 |
|
|
2017
Q1 | – | Sell |
-14,045
| Closed | -$433K | – | 1814 |
|
|
2016
Q4 | $433K | Buy |
+14,045
| New | +$434K | 0.03% | 734 |
|
|
2015
Q1 | – | Sell |
-11,081
| Closed | -$219K | – | 2046 |
|
|
2014
Q4 | $219K | Buy |
+11,081
| New | +$248K | 0.01% | 1452 |
|
Other funds holding RGEN
UCFA
CIP
Cubist Systematic Strategies's RGEN Position: Q3 2025 in Review
Cubist Systematic Strategies reduced its Repligen (RGEN) stake by 100% in Q3 2025, selling an estimated $7.4M and leaving 193 shares worth $25.8K. The position accounts for ﹤0.01% of the portfolio, ranked #2887.
Cubist Systematic Strategies first reported a position in RGEN in Q4 2014 and has held it in 28 quarters since. The position peaked at $10.8M in Q3 2022. 451 funds tracked by Wall St. Rank hold RGEN as of Q3 2025.
- Cubist Systematic Strategies held 193 shares of Repligen worth $25.8K as of Q3 2025.
- Cubist Systematic Strategies sold 60,897 Repligen shares in Q3 2025, an estimated $7.4M.
- Repligen made up ﹤0.01% of Cubist Systematic Strategies's portfolio in Q3 2025, its #2887 holding.
- Cubist Systematic Strategies first reported a position in Repligen in Q4 2014 and has held it in 28 quarters since.
- Cubist Systematic Strategies's Repligen position peaked at $10.8M in Q3 2022.
- 451 funds tracked by Wall St. Rank held Repligen as of Q3 2025.
Based on Cubist Systematic Strategies's 13F filing for Q3 2025, filed 14 Nov 2025.